These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2554076)

  • 21. [Evaluation of detecting 9 tumor markers in serum for diagnosis of primary liver cancer].
    Zeng XM
    Zhonghua Zhong Liu Za Zhi; 1993 Nov; 15(6):427-30. PubMed ID: 8200280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The role of tumor markers in the diagnosis and follow-up of liver tumors].
    Ottó S
    Orv Hetil; 2004 Feb; 145(7 Suppl 1):385-7. PubMed ID: 15049057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Marked episodic elevations of alpha-fetoprotein without hepatocellular carcinoma in a patient with hepatitis B.
    Wong CB; Attar BM; Shimoda SS
    Am J Gastroenterol; 1995 Jun; 90(6):1015-6. PubMed ID: 7539578
    [No Abstract]   [Full Text] [Related]  

  • 24. [Screening for hepatocellular carcinoma].
    Leone N; Rizzetto M
    Minerva Med; 2005 Apr; 96(2):95-108. PubMed ID: 16172579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alpha-fetoprotein and hepatocellular carcinoma.
    Colli A; Fraquelli M; Conte D
    Am J Gastroenterol; 2006 Aug; 101(8):1939; author reply 1940-1. PubMed ID: 16928257
    [No Abstract]   [Full Text] [Related]  

  • 26. Serum alpha-1-antitrypsin and alpha-1-antichymotrypsin in the diagnosis of primary hepatocellular carcinoma.
    Xu KC; Wei Q; Meng XY
    Chin Med J (Engl); 1989 Nov; 102(11):834-8. PubMed ID: 2561553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Significance of RCAS1 antigen in hepatocellular, cholangiocellular and pancreatic carcinomas.
    Enjoji M; Nakashima M; Yamaguchi K; Kotoh K; Nakamuta M
    J Gastroenterol Hepatol; 2005 Aug; 20(8):1143-8. PubMed ID: 16048560
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum markers of hepatocellular carcinoma.
    Spangenberg HC; Thimme R; Blum HE
    Semin Liver Dis; 2006 Nov; 26(4):385-90. PubMed ID: 17051452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The diagnostic utility of serum ferritin. Estimation in patients with primary hepatocellular carcinoma.
    Ola SO; Akanji AO; Ayoola EA
    Trop Geogr Med; 1995; 47(6):302-4. PubMed ID: 8650746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of mitochondrial DNA alterations in the serum of hepatocellular carcinoma patients.
    Okochi O; Hibi K; Uemura T; Inoue S; Takeda S; Kaneko T; Nakao A
    Clin Cancer Res; 2002 Sep; 8(9):2875-8. PubMed ID: 12231530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fibrolamellar carcinoma of the liver with a mixture of ordinary hepatocellular carcinoma: a case report.
    Okano A; Hajiro K; Takakuwa H; Kobashi Y
    Am J Gastroenterol; 1998 Jul; 93(7):1144-5. PubMed ID: 9672347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of ROBO1 as a novel hepatocellular carcinoma antigen and a potential therapeutic and diagnostic target.
    Ito H; Funahashi S; Yamauchi N; Shibahara J; Midorikawa Y; Kawai S; Kinoshita Y; Watanabe A; Hippo Y; Ohtomo T; Iwanari H; Nakajima A; Makuuchi M; Fukayama M; Hirata Y; Hamakubo T; Kodama T; Tsuchiya M; Aburatani H
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3257-64. PubMed ID: 16740745
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased level of serum hepatocyte growth factor/scatter factor in liver cancer is associated with tumor metastasis.
    Junbo H; Li Q; Zaide W; Yunde H
    In Vivo; 1999; 13(2):177-80. PubMed ID: 10363175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum levels of circulating intercellular adhesion molecule 1 in hepatocellular carcinoma.
    Hamazaki K; Gochi A; Shimamura H; Kaihara A; Maruo Y; Doi Y; Orita K; Lygidakis NJ
    Hepatogastroenterology; 1996; 43(7):229-34. PubMed ID: 8682469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevation of serum type IV collagen in liver cancer as well as liver cirrhosis.
    Hong WS; Hong SI; Park SY; Son Y; Lee YS; Chung YH; Yang SK; Suh DJ; Min YI
    Anticancer Res; 1995; 15(6B):2777-80. PubMed ID: 8669863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ratio of serum ornithine carbamoyltransferase to alanine aminotransferase as a potent indicator for hepatocellular carcinoma.
    Murayama H; Fukuda Y; Tsunekawa S; Ikemoto M; Nagata A
    Clin Biochem; 2007 Sep; 40(13-14):1077-80. PubMed ID: 17570354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The des-gamma-carboxyprothrombin for the diagnosis of hepatocellular carcinoma.
    Brunello F; Marcarino C; Pasquero P; Gastaldi P; Gonella S; Martini S; Calcamuggi G; Emanuelli G
    Ital J Gastroenterol; 1993 Jan; 25(1):9-12. PubMed ID: 7679014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Discriminant function based on serum analyte for diagnosis of primary hepatic cancer].
    Yi B; Luo JQ; Tang Y; Huang YD
    Hunan Yi Ke Da Xue Xue Bao; 2000 Aug; 25(4):373-5. PubMed ID: 12206007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
    Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cryosurgery causes a profound reduction in tumor markers in hepatoma and noncolorectal hepatic metastases.
    Bilchik AJ; Sarantou T; Wardlaw JC; Ramming KP
    Am Surg; 1997 Sep; 63(9):796-800. PubMed ID: 9290524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.